LEMTRADA alemtuzumab 10 mg/mL injection concentrated vial

Sanofi-Aventis Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 7dc9e54a738339cb
Product Name: LEMTRADA alemtuzumab 10 mg/mL injection concentrated vial
Artg Id: 200941
Artg Name: LEMTRADA alemtuzumab 10 mg/mL injection concentrated vial
Sponsor: Sanofi-Aventis Australia Pty Ltd
Company Detail Path: /organization/sanofi-aventis-australia-pty-ltd
Artg Date: 2013-12-18
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/167e95a27d4748b7a8aa5e4f98d34828.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/0b37802e3e711d063e8d0627957ec57e.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

7dc9e54a738339cb

Type

Standard